» » The Lancet Respiratory Medicine: Intermittent Montelukast in Children Aged 10 Months to 5 Years With Wheeze (WAIT Trial)

The Lancet Respiratory Medicine: Intermittent Montelukast in Children Aged 10 Months to 5 Years With Wheeze (WAIT Trial)

A study compared effectiveness of intermittent montelukast with placebo in reducing wheezing episodes in 1358 children aged 10 months to 5 years and whether genotype determined the patient outcome. Study authors found that intermittent montelukast only reduced wheezing episodes in children with arachidonate 5-lipoxygenase (ALOX5) gene promoter 5/5, a gene that has previously been associated with a better response to montelukast in adults. There was no correlation ...

Read More
You have just read an article categorized health titled The Lancet Respiratory Medicine: Intermittent Montelukast in Children Aged 10 Months to 5 Years With Wheeze (WAIT Trial).
Written by: editor - Tuesday, September 9, 2014

There are currently no comments for "The Lancet Respiratory Medicine: Intermittent Montelukast in Children Aged 10 Months to 5 Years With Wheeze (WAIT Trial)"

Post a Comment

Subscribe to: Post Comments (Atom)